Given its role in modulating mitochondrial homeostasis and glial activation, the main objective of this study was to determine whether pharmacological modulation of TSPO could attenuate retinal degeneration by acting on two key pathological mechanisms: chronic inflammation and oxidative stress, both of which are responsible for photoreceptor death and disease progression. This evidence concerns the gene TSPO and retinal degeneration.